SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-053729
Filing Date
2021-11-03
Accepted
2021-11-03 07:21:56
Documents
109
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20210930.htm   iXBRL 10-Q 5522579
2 EX-10.1 ex101.htm EX-10.1 294798
3 EX-10.2 ex102.htm EX-10.2 161738
4 EX-10.3 ex103.htm EX-10.3 210712
5 EX-31.1 hznp-ex311_878.htm EX-31.1 16081
6 EX-31.2 hznp-ex312_877.htm EX-31.2 15834
7 EX-32.1 hznp-ex321_876.htm EX-32.1 8971
8 EX-32.2 hznp-ex322_875.htm EX-32.2 8992
  Complete submission text file 0001564590-21-053729.txt   19337710

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA hznp-20210930.xsd EX-101.SCH 108024
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20210930_cal.xml EX-101.CAL 85411
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20210930_def.xml EX-101.DEF 410618
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20210930_lab.xml EX-101.LAB 723453
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20210930_pre.xml EX-101.PRE 641992
14 EXTRACTED XBRL INSTANCE DOCUMENT hznp-10q_20210930_htm.xml XML 3785587
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 211373717
SIC: 2834 Pharmaceutical Preparations